EUVIMEDEUVIMED entdecken
Crossref

Japanese spotted fever and adjunctive fluoroquinolones: a critical appraisal of hard outcome evidence

Eiichiro Sando

FUKUSHIMA JOURNAL OF MEDICAL SCIENCE · 2026

DOI: 10.5387/fms.26-00024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift FUKUSHIMA JOURNAL OF MEDICAL SCIENCE, 2026. Verfasst von Eiichiro Sando. Beteiligte Einrichtung: Department of Infection Control, Fukushima Medical University. Die Arbeit nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Japanese spotted fever (JSF) is a tick-borne disease caused by Rickettsia japonica, for which tetracycline-based therapy has long been the standard treatment. Since the early 2000s, adjunctive fluoroquinolone use has become more common in severe cases. However, its impact on hard outcomes has not been established. This review examines the emergence of combination therapy. It appraises the evidence by focusing on study design, escalation timing, and outcome definitions. Two retrospective cohort studies found no mortality benefit with combination therapy. One of these cohort studies also suggested possible harm in a subgroup analysis. A pooled analysis of case reports and case series described shorter time to defervescence with combination therapy, but these data are vulnerable to reporting bias, and defervescence does not demonstrate benefit in hard outcomes. Overall, current evidence is insufficient to support routine adjunctive fluoroquinolone use.

Schlagwörter

Stichwörter der Autor:innen

Japanese spotted feverRickettsia japonicacombination therapyfluoroquinolonemortality

Autor:innen und Institutionen

  • Department of Infection Control, Fukushima Medical University.

Zitieren

APA

Sando, E. (2026). Japanese spotted fever and adjunctive fluoroquinolones: a critical appraisal of hard outcome evidence. FUKUSHIMA JOURNAL OF MEDICAL SCIENCE. https://doi.org/10.5387/fms.26-00024

Vancouver

Sando E. Japanese spotted fever and adjunctive fluoroquinolones: a critical appraisal of hard outcome evidence. FUKUSHIMA JOURNAL OF MEDICAL SCIENCE. 2026. doi:10.5387/fms.26-00024

BibTeX
@article{Sando2026,
  author = {Sando, Eiichiro},
  title = {Japanese spotted fever and adjunctive fluoroquinolones: a critical appraisal of hard outcome evidence},
  journal = {FUKUSHIMA JOURNAL OF MEDICAL SCIENCE},
  year = {2026},
  doi = {10.5387/fms.26-00024}
}
Kostenlos starten →